Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signalsLaura Gatti, Paola Perego, Alexandra Sevko et al.|Oncotarget|2014Cited by 30